Moreover, we noted a pronounced upregulation of the eIF2α-ATF4-ASNS signaling pathway, coupled with a discernible reliance on ASNS in KEAP1-deficient NSCLC cells. The gene discussed is EIF2A; the disease is non-small cell lung carcinoma.